QUADRANT CAPITAL GROUP LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$36,930
-21.8%
803
-2.3%
0.00%
-20.0%
Q2 2023$47,241
+55.1%
822
+1.2%
0.01%
+66.7%
Q1 2023$30,450
+261.0%
812
+169.8%
0.00%
+200.0%
Q4 2022$8,434
-23.3%
301
-25.5%
0.00%0.0%
Q3 2022$11,000
+37.5%
404
+78.0%
0.00%0.0%
Q2 2022$8,000
-42.9%
227
-42.4%
0.00%
-50.0%
Q1 2022$14,000
+133.3%
394
+60.8%
0.00%
+100.0%
Q4 2021$6,000
-14.3%
245
-31.2%
0.00%0.0%
Q3 2021$7,000
+250.0%
356
+229.6%
0.00%
Q2 2021$2,0000.0%108
-8.5%
0.00%
Q1 2021$2,000
+100.0%
118
+114.5%
0.00%
Q4 2020$1,0000.0%550.0%0.00%
Q3 2020$1,0000.0%550.0%0.00%
Q2 2020$1,0000.0%550.0%0.00%
Q1 2020$1,000
-98.1%
55
-97.9%
0.00%
-100.0%
Q2 2019$54,000
+1.9%
2,6360.0%0.01%0.0%
Q1 2019$53,0002,6360.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders